FindTrial
Sign In

TO STUDY THE EFFICACY OF DRUG NAMED SPILANTHES ACMELLA MURR. IN THE FORM OF SUPPOSITORY IN THE MANAGEMENT OF POST-OPERATIVE PAIN IN ANO RECTAL SURGERIES LIKE PARTIAL SPHINCTEROTOMY

A RANDOMIZED OPEN LABEL CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SPILANTHES ACMELLA MURR. SUPPOSITORY IN THE MANAGEMENT OF POST-OPERATIVE PAIN IN ANO-RECTAL SURGERIES WITH SPECIAL REFERENCE TO PARTIAL SPHINCTEROTOMY. - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081625
Enrollment
30
Registered
2025-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K602- Anal fissure, unspecified

Interventions

None listed

Sponsors

Dr YASHASSU T KULOOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects with post-operative pain who underwent partial sphincterotomy under local anesthesia irrespective of gender, religion, occupation and socio-economic status will be randomly selected for study. 2)Subjects between age group of 21-60 years. 3)Subjects willing to give consent.

Exclusion criteria

Exclusion criteria: 1)Subjects with a known allergic reaction to Diclofenac sodium. 2)Subjects suffering from infectious diseases like HIV, Hepatitis and Tuberculosis. 3)Immunocompromised subjects.

Design outcomes

Primary

MeasureTime frame
Significant reduction in post-operative painTimepoint: 3 DAYS—

Secondary

MeasureTime frame
To improve the quality of life.[SF-36] - Generation of in-depth analyzed data on different aspect of the disease. - Generation of the data on possible unexpected adverse reaction.Timepoint: 3 DAYS—

Countries

India

Contacts

Public ContactDr YASHASSU T KULOOR

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH

drpadmabhats@gmail.com9900410580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026